Mérieux Equity Partners acquires majority stake in curea medical
Mérieux Equity Partners has taken a majority stake in curea medical, a carve-out from McAirlaid’s, through its buyout fund Mérieux Participations 4. The investment will fuel curea’s continued growth and innovation in advanced wound care, alongside an accelerated international expansion strategy.
